Cargando…
Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs
Key Points: - Representatives of the pharmaceutical industry call for a broader recognition of value within the assessment and appraisal of innovative drugs; - Focus on value within the assessment and appraisal of drugs is jeopardized by financial drives as the side of industry and at the side of th...
Autores principales: | Pauwels, Kim, Huys, Isabelle, Casteels, Minne, Simoens, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887481/ https://www.ncbi.nlm.nih.gov/pubmed/27313529 http://dx.doi.org/10.3389/fphar.2016.00144 |
Ejemplares similares
-
Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future
por: Pauwels, Kim, et al.
Publicado: (2017) -
Drug shortages in European countries: a trade-off between market attractiveness and cost containment?
por: Pauwels, Kim, et al.
Publicado: (2014) -
Time Investment in Drug Supply Problems by Flemish Community Pharmacies
por: De Weerdt, Elfi, et al.
Publicado: (2017) -
Toward a European definition for a drug shortage: a qualitative study
por: De Weerdt, Elfi, et al.
Publicado: (2015) -
Insights into European Drug Shortages: A Survey of Hospital Pharmacists
por: Pauwels, Kim, et al.
Publicado: (2015)